RARG Knockout HAP1 Cell Line

The choice depends on whether you are studying RARG (retinoic acid receptor γ)'s role as a tissue-restricted retinoic acid receptor or its specific contributions distinct from RARA and RARB. The Knockout line is appropriate for asking whether RARG is required for retinoic acid signaling in contexts where it predominates — RARG is principally expressed in skin, lung, and cartilage and partners with RXRs to drive retinoic acid response. Overexpression is useful for studying RARG-specific functions in heterologous contexts. Important consideration: RARA, RARB, and RARG share substantial functional overlap with overlapping retinoic acid responsive element binding — single RARG knockout in HAP1 may show modest phenotypes if RARA and RARB compensate. The EDITGENE Knockout in HAP1 is most informative when RARA/RARB expression is assessed. Rescue with wild-type or DNA-binding/ligand-binding-deficient RARG enables structure-function studies. RARG-selective agonists (CD437, CD2325, palovarotene) specificity testing benefits from this knockout — palovarotene is approved for fibrodysplasia ossificans progressiva.

Primary applications: • Retinoic acid responsive transcription: DR5-element reporter assays to assess RARG-dependent retinoid signaling. • RARG-selective agonist pharmacology: palovarotene, CD437, CD2325, MM11253 specificity testing — palovarotene is FDA-approved for fibrodysplasia ossificans progressiva. • RAR paralog studies: RARA and RARB expression analysis to interpret RARG-specific contributions versus paralog compensation. • Retinoic acid signaling biology: target gene expression analysis for canonical RA-responsive genes. EDITGENE recommends this model for researchers investigating RARG-specific retinoic acid signaling, RARG-targeted pharmacology, and retinoid family receptor specialization.

Yes. RARG rescue experiments require attention to nuclear receptor architecture: • Construct design: use a codon-modified RARG sequence with a small C-terminal tag (FLAG, HA). RARG has canonical nuclear receptor architecture (A/B with AF-1, DBD, hinge, LBD with AF-2) — preserve all elements. • DNA-binding-deficient rescue: zinc finger DBD mutations abolish DR-element binding and serve as transcription-specificity controls. • Ligand-binding-deficient rescue: LBD mutations affecting retinoic acid binding enable distinguishing ligand-dependent from constitutive activities. • Functional readout: rescue should restore retinoid-induced DR5-element reporter activity and target gene expression specific to RARG-driven programs. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.